The roundup is formatted with the title of the story, followed by the news source in parentheses and a brief summary. If you find a particularly interesting article, please send it to email@example.com for inclusion in next week’s roundup.
National Institutes of Health
NIH’s basic medical institute puts squeeze on well-supported investigators (ScienceNOW) The National Institute of General Medical Sciences will impose a strict one-grant limit on scientists who already have plentiful no-strings support beginning in January 2016.
Exceptional opportunities in medical science: a view from the NIH (JAMA, opinion) Francis Collins argues that scientific and technological breakthroughs that have arisen from NIH-supported research account for many of the gains that the U.S. has seen in health and longevity.
Top 10 medical research issues and trends to watch in 2015 (Huffington Post blog) Among the 10 issues Faster Cures is watching are the 21st Century Cures legislation and the future of academic research.
The GOP is not at war with science (Politico, opinion) Sen. Rand Paul, R-Ky., and Rep. Lamar Smith, R-Texas, argue that Republicans are not anti-science but are instead trying to ensure the best science is funded.
Innovation deficit threatens America’s health and prosperity (Roll Call, opinion) Research in Kansas drives a number of medical and economic benefits. However, decreased investments in the NIH will erode America’s traditional leadership in innovation.
The anatomy of medical research: U.S. and international comparisons (JAMA) A comparison between medical research in the U.S. and abroad shows new investments are required if the clinical value of past scientific discoveries and opportunities to improve care is to be fully realized. Analysis also shows that the U.S. will no longer be the global leader in research if additional investments are not made.
Supporting biomedical research: meeting challenges and opportunities at HHMI (JAMA, opinion) Leaders at the Howard Hughes Medical Institute are concerned that basic discovery research and early career investigators are not adequately funded, creating major challenges for the research enterprise.